Rani Therapeutics, the creator of the robotic RaniPill capsule designed to replace injections of large drug molecules, announced on Friday that it has named Svai Sanford as its first Chief Financial Officer.
Sanford is to report directly to Rani Therapeutics' Chairman & CEO, Mir Imran. Sanford will be responsible for the company's finances, accounting, administration and investor relations.
Sanford has more than two decades of experience as an executive in finance and operations in the biotech, pharmaceuticals and technology industries. He led acquisition, IPO, and financing strategy and execution at companies including SFJ Pharmaceuticals, VIVUS Inc and Elan.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer